Identifying novel glioma associated pathways based on systems biology level meta-analysis

BMC Systems Biology

Volumn 7, Issue , 2013, Pages

  Hu, Yangfan ^a   Li, Jinquan ^b   Yan, Wenying ^a   Chen, Jiajia ^a,c   Li, Yin ^a   Hu, Guang ^a   Shen, Bairong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c SUZHOU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; DNA MICROARRAY; DRUG EFFECT; EPITHELIAL MESENCHYMAL TRANSITION; GENE ONTOLOGY; GENETIC DATABASE; GENETICS; GLIOMA; HUMAN; META ANALYSIS; METHODOLOGY; PATHOLOGY; SYSTEMS BIOLOGY;

DATABASES, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE ONTOLOGY; GLIOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SYSTEMS BIOLOGY; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84908887550     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-7-S2-S9     Document Type: Article

References (48)

1. Khalil IG, Hill C: Systems biology for cancer. Curr Opin Oncol 2005, 17:44-8
2. Faratian D, Goltsov A, Lebedeva G, Sorokin A, Moodie S, Mullen P, et al: Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer Res 2009, 69:6713-20
3. Cesanaa M, Daleya GQ: Deciphering the rules of ceRNA networks. Proc Natl Acad Sci USA 2013, 110:7112-13
4. Shen K, Tseng GC: Meta-analysis for pathway enrichment analysis when combining multiple genomic studies. Bioinformatics 2010, 26:1316-23
5. Martinho O, Granja S, Jaraquemada T, Caeiro C, Miranda-Goncalves V, Honavar M, et al: Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One 2012, 7:e30769
6. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, et al: Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004, 64:6892-9
7. Ein-Dor L, Kela I, Getz G, Givol D, Domany E: Outcome signature genes in breast cancer: is there a unique set? Bioinformatics 2005, 21:171-8
8. Katara P, Neeru S, Sugandha S, Indu K, Akansha K, Lalima K, Vinay S: Comparative microarray data analysis for the expression of genes in the pathway of glioma. Bioinformation 2010, 5(1):31-4
9. Li W, Liu XR, Zhang B, Qi DX, Zhang LH, Jin YH, et al: Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion. J Exp Clin Cancer Res 2010, 29:89
10. Hu Y, Li J, Chen J, Hu G, Shen B: Identifying novel glioma associated pathways based on integrated 'omics' data. IEEE International Conference on Systems Biology IEEE; 2012, 49-55
11. Han L, Yue X, Zhou X, et al: MicroRNA-21 Expression is regulated by betacatenin/ STAT3 Pathway and Promotes Glioma Cell Invasion by Direct Targeting RECK. CNS Neurosci Ther 2012, 18:573-83
12. Fang XF, Yoon JG, Li LS, Yu W, Shao JF, Hua DS, et al: The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics 2011, 12:11
13. MacDonald JW, Ghosh D: COPA-cancer outlier profile analysis. Bioinformatics 2006, 22:2950-1
14. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-50
15. Sottoriva A, Spiteri I, Piccirillo SGM, Touloumis A, Collins VP, Marioni JC, et al: Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 2013, 110(10):4009-14
16. Baggerly KA, Coombes KR, Hess KR, Stivers DN, Abruzzo LV, Zhang W: Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol 2001, 8(6):639-59
17. Wu B: Cancer outlier differential gene expression detection. Biostatistics 2007, 8(3):566-75
18. Wang Y, Chen JJ, Li QH, Wang HY, Liu GQ, Jing Q, et al: Identifying novel prostate cancer associated pathways based on integrative microarray data analysis. Comput Biol Chem 2011, 35:151-8
19. Lee RC, Feinbaum RL, Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-54
20. Gregory RI, Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res 2005, 65(9):3509-12
21. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 2006, 6(11):857-66
22. Esquela-Kerscher A, Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4):259-69
23. Ren Y, Zhou X, Mei M, Yuan XB, Han L, Wang GX, et al: MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol. BMC Cancer 2010, 10:27
24. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL: BLAST+: architecture and applications. BMC Bioinformatics 2009, 10:421
25. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS: Human MicroRNA targets. PLoS Biol 2004, 2(11):e363
26. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R: Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10(10):1507-17
27. Sturm M, Hackenberg M, Langenberger D, Frishman D: TargetSpy: a supervised machine learning approach for microRNA target prediction. BMC Bioinformatics 2010, 11:292
28. Park PJ: ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet 2009, 10:669-80
29. Johnson DS, Mortazavi A, Myers RM, Wold B: Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502
30. Robertson G, Hirst M, Bainbridge M, et al: Genome-wide profiles of STAT1 DNA association using chromatin immuno-precipitation and massively parallel sequencing. Nat Methods 2007, 4(8):651-57
31. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al: Model-based analysis of ChIP-seq (MACS). Genome Biol 2008, 9(9):R137
32. Jothi R, Cuddapah S, Barski A, Cui K, Zhao K: Genome-wide identification of in vivo protein-DNA binding sites from ChIP-seq data. Nucleic Acids Res 2008, 36(16):5221-31
33. Salmon-Divon M, Dvinge H, Tammoja K, Bertone P: PeakAnalyzer: Genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 2010, 11:415
34. Xia M, Hu MH, Wang J, Xu YJ, Chen XB, Ma YD, et al: Identification of the role of Smad interacting protein 1 (SIP1) in glioma. J Neurooncol 2010, 97(2):225-32
35. Penuelas S, Anido J, Prieto-Sanchez RM, Folch G, Barba I, Cuartas I, et al: TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009, 15(4):315-27
36. Jiang L, Mao P, Song L, Wu J, Huang J, Lin C, et al: miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 2010, 177(1):29-38
37. Zhang C, Zhang J, Hao J, Shi Z, Wang Y, Han L, et al: High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 2012, 10:119
38. Abdoon AS, Ghanem N, Kandil OM, Gad A, Schellander K, Tesfaye D: cDNA microarray analysis of gene expression in parthenotes and in vitro produced buffalo embryos. Theriogenology 2012, 77(6):1240-51
39. Gravendeel LAM, Kouwenhoven MCM, Gevaert O, de Rooi JJ, Stubbs AP, Duijm JE, et al: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. Cancer Res 2009, 69(23):9065-72
40. Dreyfuss JM, Johnson MD, Park PJ: Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers. Mol Cancer 2009, 8:71
41. Wang Q, Xu W, Habib N, Xu R: Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. Cur Cancer Drug Targ 2009, 9:572-94
42. Gilmore TD, Koedood M, Piffat KA, White DW: Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 1996, 13(7):1367-78
43. Lee CH, Jeon YT, Kim SH, Song YS: NF-kappaB as a potential molecular target for cancer therapy. Biofactors 2007, 29(1):19-35
44. Lerebours F, Vacher S, Andrieu C, Espie M, Marty M, Lidereau R, et al: NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 2008, 8:41
45. Rhodes DR, Yu JJ, Shanker K, Deshpande N, Varambally R, Ghosh D, et al: Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci USA 2004, 101(25):9309-14
46. Eschrich SA, Hoerter AM: Libaffy: software for processing Affymetrix(R) GeneChip(R) data. Bioinformatics 2007, 23(12):1562-64
47. Chung NJ, Zhang XD, Kreamer A, Locco L, Kuan PF, Bartz S, et al: Median absolute deviation to improve hit selection for genome-scale RNAi screens. J Biomol Screen 2008, 13(2):149-58
48. Elins S, Bugrim A, Brovold L, Kirillov E, Nikolsky Y, Rakhmatulin E, et al: Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 2006, 36(10-11):877-901